Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$121K Hold
333
0.05% 103
2026
Q1
$117K Hold
333
0.05% 97
2025
Q4
$109K Sell
333
-244
-42% -$77.4K 0.05% 101
2025
Q3
$163K Sell
577
-410
-42% -$119K 0.07% 86
2025
Q2
$276K Buy
987
+409
+71% +$116K 0.14% 66
2025
Q1
$180K Hold
578
0.1% 73
2024
Q4
$151K Sell
578
-1
-0.2% -$297 0.09% 80
2024
Q3
$187K Hold
579
0.1% 69
2024
Q2
$181K Hold
579
0.11% 74
2024
Q1
$165K Hold
579
0.13% 75
2023
Q4
$167K Buy
+579
New +$158K 0.11% 73

Other funds holding AMGN

Aspect Partners's AMGN Position: Q2 2026 in Review

Aspect Partners held its Amgen (AMGN) position steady in Q2 2026 at 333 shares worth $121K. The position accounts for 0.05% of the portfolio, ranked #103.

Aspect Partners first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $276K in Q2 2025. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Aspect Partners held 333 shares of Amgen worth $121K as of Q2 2026.
  • Aspect Partners left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.05% of Aspect Partners's portfolio in Q2 2026, its #103 holding.
  • Aspect Partners first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Aspect Partners's Amgen position peaked at $276K in Q2 2025.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.